OPEN Foundation is a nonprofit organisation based in the Netherlands that envisions a world where safe, beneficial, and accessible applications of psychedelics are ethically and responsibly integrated into science, healthcare, and society. OPEN hosts the biennial Interdisciplinary Conference on Psychedelic Research (ICPR), Europe's premier psychedelic research conference. Norrsken Mind supported both the 2024 and 2026 conferences.

PsyPAN is a non-profit organisation created to connect and empower all psychedelic participants, whether they are taking part in clinical trials or receiving therapy at the various legal treatment centres being set up globally.

IAMHRF was created to unite public and private funders of mental health research. Members include the world’s largest government, foundation and charity funders of mental health research. They support work across the full spectrum of discovery to implementation research. Norrsken Mind became a member in 2026.

PsyPal is a randomized controlled trial across four countries that will investigate whether psilocybin therapy can help ease psychological and existential distress in patients suffering from four progressive diseases. PsyPal is funded by the European Union and Norrsken Mind is one of 19 partners in the project consortium.

NPV, or the Swedish Network for Psychedelic Science, is a non-profit member association with the purpose of promoting research on psychedelics. The association has over 1000 members and organizes lectures and seminars related to psychedelic science.

PAREA is a non-profit, multistakeholder and multidisciplinary partnership, and Norrsken Mind is one of its Founding Members. By combining and streamlining the knowledge and expertise of its members, PAREA brings comprehensive advice and guidance to EU policymakers – whilst delivering value to society in the process.

Usona Institute is a non-profit medical research organization based in Madison, Wisconsin. Usona is dedicated to supporting and conducting pre-clinical and clinical research to further the understanding of the therapeutic effects of psilocybin and other psychedelics. Norrsken Mind is collaborating with Usona to provide qualified researchers with pharmaceutical-grade psilocybin.

Blossom is a platform dedicated to making psychedelic science accessible, offering comprehensive databases, reports and insights on the latest developments in the psychedelic field.

Osmond Labs catalyzes psychedelic clinical research on set & setting, and brings optimized treatment protocols into society. Osmond Labs offers advisory services to researchers seeking to procure GMP-grade psychedelic compounds for clinical trials.